Advertisement

A 2-year survey of treatment of acute atrial fibrillation in an ED

      Abstract

      Objective

      Pharmacologic cardioversion of atrial fibrillation (AF) is a reasonable mode of treatment if the arrhythmia is of recent onset. Results concerning the response rates of different drugs, respectively, in daily clinical practice and data with regard to the parameters associated with successful cardioversion are not very prevalent.

      Methods

      Three-hundred seventy-six patients who were admitted to the emergency department with acute AF and a duration of shorter than 48 hours were enrolled into the AF registry.

      Results

      The most effective drugs were flecainide and ibutilide (95% and 76%). Low response rates were observed with amiodarone (36%) and the individual use of digoxin or diltiazem (19% and 18%). Factors associated with a successful cardioversion were a lower blood pressure on admission (P = .002), a shorter time interval between the onset of AF and admission to the ED (P = .003), and adherence to treatment guidelines (P < .0001).

      Conclusion

      The use of flecainide and ibutilide is associated with a much higher rate of cardioversion than other drugs we studied.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D; use, select 'Corporate R&D; Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wolf P.A.
        • Dawber T.R.
        • Thomas H.E.
        • et al.
        Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.
        Neurology. 1978; 28: 973-977
        • Krahn A.D.
        • Manfreda J.
        • Tate R.B.
        • et al.
        The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.
        Am J Med. 1995; 98: 476-484
        • Go A.S.
        • Hylek E.M.
        • Phillips K.A.
        • et al.
        Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
        JAMA. 2001; 285: 2370-2375
        • Psaty B.M.
        • Manolio T.A.
        • Kuller L.H.
        • et al.
        Incidence of and risk factors for atrial fibrillation in older adults.
        Circulation. 1997; 96: 2455-2461
        • Fuster V.
        • Rydén L.E.
        • Cannom D.S.
        • et al.
        ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
        Europace. 2006; 9: 651-745
        • Wattanasuwan N.
        • Khan I.A.
        • Nirav J.M.
        • et al.
        Acute ventricular rate control in atrial fibrillation.
        Chest. 2001; 119: 502-506
        • Boriani G.
        • Biffi M.
        • Diemberger I.
        • et al.
        Rate control in atrial fibrillation. Choice of treatment and assessment of efficacy.
        Drugs. 2003; 63: 1489-1509
        • Williams E.
        • Ansari M.
        • Lip G.Y.H.
        Managing atrial fibrillation in the accident and emergency department.
        QJ Med. 2001; 94: 509-614
        • Donovan K.D.
        • Dobb G.J.
        • Coombs L.J.
        • et al.
        Efficacy of flecainide for the reversion of acute onset atrial fibrillation.
        Am J Cardiol. 1992; 70: 50A-55A
        • Martinez-Marcos F.J.
        • Garcia-Garmendia J.L.
        • Ortega-Carpio A.
        • et al.
        Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
        Am J Cardiol. 2000; 86: 950-953
        • Reisinger J.
        • Gatterer E.
        • Lang W.
        • et al.
        Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.
        Eur Heart J. 2004; 25: 1318-1324
        • McNamara R.L.
        • Tamariz L.J.
        • Segal J.B.
        • et al.
        Management of atrial fibrillation: review of the evidence for the role of pharmacological therapy, electrical cardioversion, and echocardiography.
        Ann Intern Med. 2003; 139: 1018-1033
        • Kafkas N.V.
        • Patsilinakos S.P.
        • Mertzanos G.A.
        • et al.
        Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
        Int J Cardiol. 2007; 118: 321-325
        • Varriale P.
        • Sedighi A.
        Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?.
        Clin Cardiol. 2000; 23: 265-268
        • Bianconi L.
        • Castro A.
        • Dinelli M.
        • et al.
        Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter.
        Eur Heart J. 2000; 21: 1265-1273
        • Galve E.
        • Rius T.
        • Ballester R.
        • et al.
        Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.
        J Am Coll Cardiol. 1996; 27: 1079-1082
        • Slavik S.S.
        Intravenous amiodarone for acute pharmacological conversion of atrial fibrillation in the emergency department.
        Pharmacotherapy. 2004; 4: 414-420
        • Yahalom J.
        • Klein H.O.
        • Kaplinsky E.
        Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.
        Chest. 1977; 71: 592-596
        • Khalsa A.
        • Edvardsson N.
        • Olsson S.B.
        Effects of metoprolol on heart rate in patients with digitalis treated chronic atrial fibrillation.
        Clin Cardiol. 1978; 1: 91-95
        • Slavik R.S.
        • Tisdale J.E.
        • Borzak S.
        Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.
        Prog Cardiovasc Dis. 2001; 44: 121-152
        • Tejan-Sie S.A.
        • Murray R.D.
        • Black I.W.
        • et al.
        Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: an ACUTE trial ancillary study.
        J Am Coll Cardiol. 2003; 42: 1638-1643
        • Nichol G.
        • McAlister F.
        • Pham B.
        • et al.
        Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.
        Heart. 2002; 87: 535-543
        • Cotter G.
        • Blatt A.
        • Kaluski E.
        • et al.
        Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone.
        Eur Heart J. 1999; 20: 1833-1842
        • Backer H.D.
        • Decker L.
        • Ackerson L.
        Reproducibility of increased blood pressure during an emergency department or urgent care visit.
        Ann Emerg Med. 2003; 41: 507-512
        • Dieterle T.
        • Schuurmans M.M.
        • Strobel W.
        • Battegay E.J.
        • Martina B.
        Moderate-to-severe blood pressure elevation at ED entry: hypertension or normotension?.
        Am J Emerg Med. 2005; 23: 474-479
        • Thomas M.C.
        • Dublin S.
        • Kaplan R.C.
        • et al.
        Blood pressure control and risk of incident atrial fibrillation.
        Am J Hypertens. 2008; 21: 1111-1116
        • Mitchell G.F.
        • Vasan R.S.
        • Keyes M.J.
        • et al.
        Pulse pressure and risk of new-onset atrial fibrillation.
        JAMA. 2007; 297: 709-715
        • Verdecchia P.
        • Reboldi G.
        • Gattobigio
        • et al.
        Atrial fibrillation in hypertension: predictors and outcome.
        Hypertension. 2003; 41: 218-223
        • Heskestad B.
        • Baardsen R.
        • Helseth E.
        • et al.
        Guideline compliance in management of minimal, mild, and moderate head injury: high frequency of noncompliance among individual physicians despite strong guideline support from clinical leaders.
        J Trauma. 2008; 65: 1309-1313
        • Tremey B.
        • Tazarourte K.
        • Ract C.
        • et al.
        Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation-related severe bleeding in the emergency department.
        Intensive Care Med. 2009; ([Epub ahead of print])
        • Smith C.
        • Mensah A.
        • Mal S.
        • et al.
        Is pretest probability assessment on emergency department patients with suspected venous thromboembolism documented before SimpliRED d-dimer testing?.
        CJEM. 2008; 10: 519-523